UCSF-John Muir Health Cancer Network
Top cancer specialists working together
Nationally Ranked Cancer Care for Patients in the East Bay
UCSF’s nationally top-ranked cancer program was recognized by recognized by US News and World Report as tied for the best cancer program in Northern California.
John Muir Health is accredited as an Integrated Network Cancer Program by the American College of Surgeons Commission on Cancer.
Both programs deliver comprehensive care personalized to each patient and delivered with compassion.
Our multidisciplinary teams have vast experience treating cancer, including but not limited to those of the breast, gastrointestinal tract, head and neck, lung, thyroid and prostate, as well as uterine and ovarian cancers, and hematologic cancers. Through our cancer collaboration you’ll have access to distinguished disease-specific treatment capabilities, expanded clinical trial enrollment and precision medicine offerings, close to home.
As a patient, you’ll also find a range of support services and educational resources such as nurse navigators, genetic counseling and cancer nutrition. These help you and your loved ones manage your care and become active participants in the healing process.
UCSF and John Muir Health are developing a network of cancer care centers designed to improve the prevention, diagnosis and treatment of cancer patients throughout the east bay. The joint cancer network will provide distinguished disease-specific treatment capabilities, expanded clinical trial enrollment and precision medicine offerings.
Our cancer network began with the UCSF-John Muir Health Cancer Center in Berkeley, which opened in February 2020. In 2023 existing John Muir Health Cancer Centers in Walnut Creek, Concord and Pleasant Hill will also officially become part of the network.
Central to the network is the development of a world-class cancer outpatient center, opening in Walnut Creek in early 2024, which will offer comprehensive services. These include radiation oncology treatments, an infusion center, access to clinical trials, genetic counseling, nurse navigators, support services and additional diagnostic and treatment services in a patient centered environment.